ÂÜŔňÂŇÂ×

Tamer Khayal

Chief Commercial Officer at TransMedics Group

Dr. Khayal joined TransMedics in 2001. Over the past 18 years Dr. Tamer Khayal assumed growing responsibilities to the current role of Chief Commercial Officer in January 2018. From 2007-2018 he was the Chief Medical Officer leading TransMedics’ global effort of building the clinical evidence, reimbursement initiatives and use model integration programs to support the PMA approvals and global commercial adoption of the Organ Care (OCS™) technology for lung, heart and liver transplantation. His patient focused approached to commercial rollout, made Dr. Khayal gain the trust and respect of the OCS™ users world-wide. Prior to joining TransMedics, Dr. Khayal served for six years as the Director of Medical Affairs for Zentiva Middle East, a pharmaceutical company, where he led clinical research, regulatory filings and clinical sales training for the company’s ME&A operations. Dr. Khayal received his MD degree from Cairo University School of Medicine and a General Certificate of Education from the University of London, England.

Links


Org chart